Article ID Journal Published Year Pages File Type
8232744 International Journal of Radiation Oncology*Biology*Physics 2010 6 Pages PDF
Abstract
The maximum tolerated dose was determined to be 74 Gy/37 fractions (2.0 Gy per fraction) using three-dimensional conformal radiation therapy with concurrent paclitaxel and carboplatin therapy. This dose level in the Phase II portion has been well tolerated, with low rates of acute and late lung toxicities.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117
Authors
, , , , , , , , , ,